Navigator

      Support By : Li-lab

Drugs And Genes
DRUGs and GENEs
GENE_SYMBOL HGNC_ID UNIPROT_ID DRUG_NAME PUBCHEM_CID Datasource
ADRA2A HGNC:281 P08913 N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-fluorobenzamide 44403213 TTD
ADRA2A HGNC:281 P08913 6-fluoro-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)nicotinamide 44403214 TTD
ADRA2A HGNC:281 P08913 N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-6-fluoronicotinamide 44403219 TTD
ADRA2A HGNC:281 P08913 6-fluoro-N-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]pyridine-2-carboxamide 44403220 TTD
ADRA2A HGNC:281 P08913 N-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl]-6-fluoropyridine-2-carboxamide 44403224 TTD
ADRA2A HGNC:281 P08913 4-Fluoro-N-{4-[4-(2-methoxy-phenyl)-piperazin-1-yl]-butyl}-benzenesulfonamide 44403225 TTD
ADRA2A HGNC:281 P08913 N-{4-[4-(2,3-Dichloro-phenyl)-piperazin-1-yl]-butyl}-4-fluoro-benzenesulfonamide 44403232 TTD
ADRA2A HGNC:281 P08913 11-Methyl-4-[2-[4-(2-phenylphenyl)piperazin-1-yl]ethyl]-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),5-trien-3-one 44405573 TTD
ADRA2A HGNC:281 P08913 11-Methyl-4-[2-[4-(2-phenoxyphenyl)piperazin-1-yl]ethyl]-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),5-trien-3-one 44405574 TTD
ADRA2A HGNC:281 P08913 11-Methyl-4-[2-[4-(2-phenylmethoxyphenyl)piperazin-1-yl]ethyl]-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),5-trien-3-one 44405575 TTD
ADRA2A HGNC:281 P08913 11-Methyl-4-[2-[4-(2-propan-2-yloxyphenyl)piperazin-1-yl]ethyl]-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),5-trien-3-one 44405586 TTD
ADRA2A HGNC:281 P08913 4-[2-[4-[2-(2,2-Dimethylpropoxy)phenyl]piperazin-1-yl]ethyl]-11-methyl-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),5-trien-3-one 44405587 TTD
ADRA2A HGNC:281 P08913 4-[2-[4-(2-Methoxy-5-methylphenyl)piperazin-1-yl]ethyl]-11-methyl-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),5-trien-3-one 44405655 TTD
ADRA2A HGNC:281 P08913 4-[2-[4-[2-Methoxy-5-(trifluoromethyl)phenyl]piperazin-1-yl]ethyl]-11-methyl-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),5-trien-3-one 44405665 TTD
ADRA2A HGNC:281 P08913 4-[2-[4-(2,3-Dihydro-1-benzofuran-7-yl)piperazin-1-yl]ethyl]-11-methyl-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),5-trien-3-one 44405666 TTD
ADRA2A HGNC:281 P08913 4-[2-[4-(1-Benzothiophen-7-yl)piperazin-1-yl]ethyl]-11-methyl-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),5-trien-3-one 44405669 TTD
ADRA2A HGNC:281 P08913 4-[2-[4-(4-Chloro-2-methoxyphenyl)piperazin-1-yl]ethyl]-11-methyl-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),5-trien-3-one 44405677 TTD
ADRA2A HGNC:281 P08913 11-Methyl-4-[2-(4-quinolin-5-ylpiperazin-1-yl)ethyl]-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),5-trien-3-one 44405701 TTD
ADRA2A HGNC:281 P08913 4-[2-(4-Isoquinolin-5-ylpiperazin-1-yl)ethyl]-11-methyl-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),5-trien-3-one 44405702 TTD
ADRA2A HGNC:281 P08913 4-[2-[4-(3-Chloro-2-methoxyphenyl)piperazin-1-yl]ethyl]-11-methyl-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),5-trien-3-one 44405725 TTD